Skip to main content
PMC home page
Heart logoLink to Heart
. 2001 Dec;86(6):701–708. doi: 10.1136/heart.86.6.701

Transforming growth factor-β1 expression in dilated cardiomyopathy

J SANDERSON, K LAI, I SHUM, S WEI, L CHOW
PMCID: PMC1729995  PMID: 11711472

Full Text

The Full Text of this article is available as a PDF (247.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Scattergram showing individual values for serum TGF-β1 concentrations (upper) and macrophage mRNA concentrations (lower). DCM, idiopathic dilated cardiomyopathy.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amato M. C., Moffa P. J., Werner K. E., Ramires J. A. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001 Oct;86(4):381–386. doi: 10.1136/heart.86.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson T. J. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999 Sep;34(3):631–638. doi: 10.1016/s0735-1097(99)00259-4. [DOI] [PubMed] [Google Scholar]
  3. Baba R., Nagashima M., Goto M., Nagano Y., Yokota M., Tauchi N., Nishibata K. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996 Nov 15;28(6):1567–1572. doi: 10.1016/s0735-1097(96)00412-3. [DOI] [PubMed] [Google Scholar]
  4. Baxter R., McFadden P. M., Gradman M., Wright A. Scimitar syndrome: cine magnetic resonance imaging demonstration of anomalous pulmonary venous drainage. Ann Thorac Surg. 1990 Jul;50(1):121–123. doi: 10.1016/0003-4975(90)90101-b. [DOI] [PubMed] [Google Scholar]
  5. Berkin K. E., Ball S. G. Essential hypertension: the heart and hypertension. Heart. 2001 Oct;86(4):467–475. doi: 10.1136/heart.86.4.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blobe G. C., Schiemann W. P., Lodish H. F. Role of transforming growth factor beta in human disease. N Engl J Med. 2000 May 4;342(18):1350–1358. doi: 10.1056/NEJM200005043421807. [DOI] [PubMed] [Google Scholar]
  7. Bonhoeffer P., Boudjemline Y., Saliba Z., Hausse A. O., Aggoun Y., Bonnet D., Sidi D., Kachaner J. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000 Aug 15;102(7):813–816. doi: 10.1161/01.cir.102.7.813. [DOI] [PubMed] [Google Scholar]
  8. Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D., Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000 Oct 21;356(9239):1403–1405. doi: 10.1016/S0140-6736(00)02844-0. [DOI] [PubMed] [Google Scholar]
  9. Chambers J., Das P. Treadmill exercise in apparently asymptomatic aortic stenosis. Heart. 2001 Oct;86(4):361–362. doi: 10.1136/heart.86.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohen M. C., Hartnell G. G., Finn J. P. Magnetic resonance angiography of congenital pulmonary vein anomalies. Am Heart J. 1994 Apr;127(4 Pt 1):954–955. doi: 10.1016/0002-8703(94)90575-4. [DOI] [PubMed] [Google Scholar]
  11. Di Somma S., Marotta M., Salvatore G., Cudemo G., Cuda G., De Vivo F., Di Benedetto M. P., Ciaramella F., Caputo G., de Divitiis O. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart. 2000 Dec;84(6):659–667. doi: 10.1136/heart.84.6.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eykyn S. J. Endocarditis: basics. Heart. 2001 Oct;86(4):476–480. doi: 10.1136/heart.86.4.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Feder J. N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D. A., Basava A., Dormishian F., Domingo R., Jr, Ellis M. C., Fullan A. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. doi: 10.1038/ng0896-399. [DOI] [PubMed] [Google Scholar]
  14. Francis D. P., Shamim W., Davies L. C., Piepoli M. F., Ponikowski P., Anker S. D., Coats A. J. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J. 2000 Jan;21(2):154–161. doi: 10.1053/euhj.1999.1863. [DOI] [PubMed] [Google Scholar]
  15. Frangogiannis N. G., Mendoza L. H., Lindsey M. L., Ballantyne C. M., Michael L. H., Smith C. W., Entman M. L. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000 Sep 1;165(5):2798–2808. doi: 10.4049/jimmunol.165.5.2798. [DOI] [PubMed] [Google Scholar]
  16. Galle J., Lehmann-Bodem C., Hübner U., Heinloth A., Wanner C. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Nephrol Dial Transplant. 2000 Mar;15(3):339–346. doi: 10.1093/ndt/15.3.339. [DOI] [PubMed] [Google Scholar]
  17. Gras D., Mabo P., Tang T., Luttikuis O., Chatoor R., Pedersen A. K., Tscheliessnigg H. H., Deharo J. C., Puglisi A., Silvestre J. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2249–2255. doi: 10.1111/j.1540-8159.1998.tb01162.x. [DOI] [PubMed] [Google Scholar]
  18. Hancock E. W. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart. 2001 Sep;86(3):343–349. doi: 10.1136/heart.86.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ho S. Y., Cabrera J. A., Tran V. H., Farré J., Anderson R. H., Sánchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart. 2001 Sep;86(3):265–270. doi: 10.1136/heart.86.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Jardine A. G., McLaughlin K. Cardiovascular complications of renal disease. Heart. 2001 Oct;86(4):459–466. doi: 10.1136/heart.86.4.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kanda T., Inoue M., Kotajima N., Fujimaki S., Hoshino Y., Kurabayashi M., Kobayashi I., Tamura J. Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology. 2000;93(3):191–196. doi: 10.1159/000007025. [DOI] [PubMed] [Google Scholar]
  22. Kaneko K., Kanda T., Yokoyama T., Nakazato Y., Iwasaki T., Kobayashi I., Nagai R. Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol. 1997 Jul;97(1):3–12. [PubMed] [Google Scholar]
  23. Kawano H., Do Y. S., Kawano Y., Starnes V., Barr M., Law R. E., Hsueh W. A. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation. 2000 Mar 14;101(10):1130–1137. doi: 10.1161/01.cir.101.10.1130. [DOI] [PubMed] [Google Scholar]
  24. Kivelitz D. E., Scheer I., Taupitz M. Scimitar syndrome: diagnosis with MR angiography. AJR Am J Roentgenol. 1999 Jun;172(6):1700–1700. doi: 10.2214/ajr.172.6.10350327. [DOI] [PubMed] [Google Scholar]
  25. Kühl U., Seeberg B., Schultheiss H. P., Strauer B. E. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J. 1994 Aug;15 (Suppl 100):62–67. doi: 10.1093/eurheartj/15.suppl_c.62. [DOI] [PubMed] [Google Scholar]
  26. Mahon N. G., Coonar A. S., Jeffery S., Coccolo F., Akiyu J., Zal B., Houlston R., Levin G. E., Baboonian C., McKenna W. J. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart. 2000 Nov;84(5):541–547. doi: 10.1136/heart.84.5.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mancini D., LeJemtel T., Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation. 2000 Mar 14;101(10):1080–1082. doi: 10.1161/01.cir.101.10.1080. [DOI] [PubMed] [Google Scholar]
  28. Mangiafico R. A., Malatino L. S., Santonocito M., Spada R. S., Polizzi G., Tamburino G. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis. Int Angiol. 1996 Sep;15(3):240–244. [PubMed] [Google Scholar]
  29. Möller J., Ahlbom A., Hulting J., Diderichsen F., de Faire U., Reuterwall C., Hallqvist J. Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP). Heart. 2001 Oct;86(4):387–390. doi: 10.1136/heart.86.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Paris D., Town T., Humphrey J., Yokota K., Mullan M. Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway. Biochem Biophys Res Commun. 2000 Aug 2;274(2):553–558. doi: 10.1006/bbrc.2000.3174. [DOI] [PubMed] [Google Scholar]
  31. Pauschinger M., Knopf D., Petschauer S., Doerner A., Poller W., Schwimmbeck P. L., Kühl U., Schultheiss H. P. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999 Jun 1;99(21):2750–2756. doi: 10.1161/01.cir.99.21.2750. [DOI] [PubMed] [Google Scholar]
  32. Prince M. R., Narasimham D. L., Jacoby W. T., Williams D. M., Cho K. J., Marx M. V., Deeb G. M. Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol. 1996 Jun;166(6):1387–1397. doi: 10.2214/ajr.166.6.8633452. [DOI] [PubMed] [Google Scholar]
  33. Rakhit R. D., Marber M. S. Nitric oxide: an emerging role in cardioprotection? Heart. 2001 Oct;86(4):368–372. doi: 10.1136/heart.86.4.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shibata M., Endo S., Inada K., Kuriki S., Harada M., Takino T., Sato N., Arakawa N., Suzuki T., Aoki H. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997 Mar;17(3):145–150. doi: 10.1089/jir.1997.17.145. [DOI] [PubMed] [Google Scholar]
  35. Tesson F., Charron P., Peuchmaurd M., Nicaud V., Cambien F., Tiret L., Poirier O., Desnos M., Jullières Y., Amouyel P. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol. 1999 May;31(5):1025–1032. doi: 10.1006/jmcc.1999.0947. [DOI] [PubMed] [Google Scholar]
  36. Verma S., Lovren F., Dumont A. S., Mather K. J., Maitland A., Kieser T. M., Triggle C. R., Anderson T. J. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg. 2000 Oct;120(4):668–671. doi: 10.1067/mtc.2000.109000. [DOI] [PubMed] [Google Scholar]
  37. White C. S., Baffa J. M., Haney P. J., Campbell A. B., NessAiver M. Anomalies of pulmonary veins: usefulness of spin-echo and gradient-echo MR images. AJR Am J Roentgenol. 1998 May;170(5):1365–1368. doi: 10.2214/ajr.170.5.9574617. [DOI] [PubMed] [Google Scholar]
  38. Whitfield J. B., Cullen L. M., Jazwinska E. C., Powell L. W., Heath A. C., Zhu G., Duffy D. L., Martin N. G. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet. 2000 Mar 15;66(4):1246–1258. doi: 10.1086/302862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yang Z., Zingarelli B., Szabó C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation. 2000 Mar 7;101(9):1019–1026. doi: 10.1161/01.cir.101.9.1019. [DOI] [PubMed] [Google Scholar]
  40. de Groote P., Millaire A., Decoulx E., Nugue O., Guimier P., Ducloux Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy. New markers of exercise intolerance with clinical implications. J Am Coll Cardiol. 1996 Jul;28(1):168–175. doi: 10.1016/0735-1097(96)00126-x. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES